172 related articles for article (PubMed ID: 36114172)
1. Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients.
Di Pietro L; Giacalone F; Ragozzino E; Saccone V; Tiberio F; De Bardi M; Picozza M; Borsellino G; Lattanzi W; Guadagni E; Bortolani S; Tasca G; Ricci E; Parolini O
Cell Death Dis; 2022 Sep; 13(9):793. PubMed ID: 36114172
[TBL] [Abstract][Full Text] [Related]
2. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
[TBL] [Abstract][Full Text] [Related]
4. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
Banerji CRS; Henderson D; Tawil RN; Zammit PS
Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
[TBL] [Abstract][Full Text] [Related]
6. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
[TBL] [Abstract][Full Text] [Related]
7. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E
PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy.
Corasolla Carregari V; Monforte M; Di Maio G; Pieroni L; Urbani A; Ricci E; Tasca G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396627
[TBL] [Abstract][Full Text] [Related]
10. Interaction between mesenchymal stem cells and myoblasts in the context of facioscapulohumeral muscular dystrophy contributes to the disease phenotype.
Kiseleva E; Serbina O; Karpukhina A; Mouly V; Vassetzky YS
J Cell Physiol; 2022 Aug; 237(8):3328-3337. PubMed ID: 35621301
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
[TBL] [Abstract][Full Text] [Related]
12. Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target.
Heher P; Ganassi M; Weidinger A; Engquist EN; Pruller J; Nguyen TH; Tassin A; Declèves AE; Mamchaoui K; Banerji CRS; Grillari J; Kozlov AV; Zammit PS
Redox Biol; 2022 May; 51():102251. PubMed ID: 35248827
[TBL] [Abstract][Full Text] [Related]
13. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
[TBL] [Abstract][Full Text] [Related]
14. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.
Homma S; Chen JC; Rahimov F; Beermann ML; Hanger K; Bibat GM; Wagner KR; Kunkel LM; Emerson CP; Miller JB
Eur J Hum Genet; 2012 Apr; 20(4):404-10. PubMed ID: 22108603
[TBL] [Abstract][Full Text] [Related]
15. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.
Tasca G; Monforte M; Corbi M; Granata G; Lucchetti D; Sgambato A; Ricci E
Mol Neurobiol; 2018 Apr; 55(4):2959-2966. PubMed ID: 28456937
[TBL] [Abstract][Full Text] [Related]
16. A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles.
Caron L; Kher D; Lee KL; McKernan R; Dumevska B; Hidalgo A; Li J; Yang H; Main H; Ferri G; Petek LM; Poellinger L; Miller DG; Gabellini D; Schmidt U
Stem Cells Transl Med; 2016 Sep; 5(9):1145-61. PubMed ID: 27217344
[TBL] [Abstract][Full Text] [Related]
17. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
[TBL] [Abstract][Full Text] [Related]
18. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
[TBL] [Abstract][Full Text] [Related]
19. DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation.
Banerji CRS; Panamarova M; Zammit PS
Hum Mol Genet; 2020 Aug; 29(14):2285-2299. PubMed ID: 32242220
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
